Gastroparesis primary prevention

Jump to navigation Jump to search

Gastroparesis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gastroparesis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastroparesis primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastroparesis primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastroparesis primary prevention

CDC on Gastroparesis primary prevention

Gastroparesis primary prevention in the news

Blogs on Gastroparesis primary prevention

Directions to Hospitals Treating Gastroparesis

Risk calculators and risk factors for Gastroparesis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Effective measures for the primary prevention of gastroparesis include strict glycemic control, nutritional therapies, having frequent, small meals that are low in fat and fiber, alcohol and smoking cessation, regular exercise and avoidance of medications that impair gastric motility.

Primary Prevention

Effective measures for the primary prevention of gastroparesis include:[1][2]

References

  1. Stein B, Everhart KK, Lacy BE (2015). "Gastroparesis: A Review of Current Diagnosis and Treatment Options". J. Clin. Gastroenterol. 49 (7): 550–8. doi:10.1097/MCG.0000000000000320. PMID 25874755.
  2. Fontana RJ, Barnett JL (1996). "Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review". Am. J. Gastroenterol. 91 (10): 2174–8. PMID 8855743.
  3. Maurer AH, Krevsky B, Knight LC, Brown K (1996). "Opioid and opioid-like drug effects on whole-gut transit measured by scintigraphy". J. Nucl. Med. 37 (5): 818–22. PMID 8965152.

Template:WH Template:WS